Hesham Elhalawani

Hesham Elhalawani, MD, MSc is an Attending Physician in the Department of Radiation Oncology and Instructor in Radiation Oncology at Harvard Medical School. He is affiliated with Dana-Farber/Boston Children's Cancer and Blood Disorders Center, where he specializes in treating pediatric cancer patients with radiation therapy.

His educational background includes:

• Medical School: Ain Shams University, Faculty of Medicine (2011, Cairo, Egypt)
• Internship: Internal Medicine, Ain Shams University (2012)
• Residency: Clinical Oncology/Nuclear Medicine, Ain Shams University (2015)
• Fellowship: Radiation Oncology, University of Texas MD Anderson Cancer Center (2019)
• Fellowship: Radiation Oncology, Cleveland Clinic Taussig Cancer Institute (2020)
• Fellowship: CNS Radiation Oncology, Brigham and Women's Hospital (2022)

Dr. Elhalawani's clinical focus centers on pediatric cancers, particularly brain tumors, bone tumors, Hodgkin lymphoma, and neuroblastoma. His research interests bridge radiation oncology with cutting-edge computational approaches, with a strong emphasis on leveraging machine learning and imaging informatics to personalize cancer care. He has developed expertise in integrating multi-parametric magnetic resonance imaging (mpMRI) and quantitative imaging analytics to advance image-guided cancer treatment and surveillance. His work has significantly contributed to the development of clinical applications of radiomics analytics in radiation oncology.

Analysis of his recent publications (2023-2025) reveals a strong research focus on applying artificial intelligence and machine learning techniques to radiation oncology, particularly for pediatric brain tumors and metastases. His work spans from developing deep learning algorithms for tumor segmentation to creating predictive models for treatment outcomes and recurrence risk. A notable trend is his integration of radiomics with genomic data to create more precise treatment approaches, as seen in his work on molecular subtyping of pediatric gliomas and genomic scores for predicting treatment response.

Dr. Elhalawani has been actively involved in several major challenges and collaborative efforts in medical imaging AI, including the Brain Tumor Segmentation (BraTS) Challenge and the HECKTOR challenge for head and neck tumor analysis. His research demonstrates a consistent pattern of bridging clinical radiation oncology with computational innovation to improve pediatric cancer outcomes.

While specific advising relationships aren't detailed in the provided information, his position as an Instructor at Harvard Medical School suggests involvement in training medical students, residents, and fellows in radiation oncology. His research program likely involves collaboration with data scientists, medical physicists, and other oncology specialists working at the intersection of AI and cancer treatment.

Dr. Elhalawani's work is primarily conducted within the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, which provides comprehensive care for children with cancer and blood disorders. His research appears to be part of larger collaborative teams focused on developing innovative approaches to pediatric radiation oncology, with particular emphasis on computational methods to enhance treatment precision and personalization.